Concepedia

David Berd

DB

77

Publications

5K

Citations

41

H-Index

1973

Active since

Affiliations

Thomas Jefferson University(Current)

Sidney Kimmel Cancer Center

Jefferson College

Wills Eye Hospital

David Berd is an author at Thomas Jefferson University specializing in medicine, immunology, and tumor microenvironment.

ORCID

Top concepts

Publications per year

1973–2015

77

Publications

77

Treatment of metastatic melanoma with an autologous tumor-cell vaccine: clinical and immunologic results in 64 patients.

David Berd, Henry Maguire, Peter A. McCue et al. · Journal of Clinical Oncology · 1990 · 298 citations

, , +18

Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide.

David Berd, Henry Maguire, Michael J. Mastrangelo · PubMed · 1986 · 252 citations

, , +18

Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma.

Masataka Ohta, Hirokazu Nagai, Makiko Shimizu et al. · PubMed · 1994 · 169 citations

, , +17

Effect of low dose cyclophosphamide on the immune system of cancer patients: depletion of CD4+, 2H4+ suppressor-inducer T-cells.

David Berd, Michael J. Mastrangelo · PubMed · 1988 · 167 citations

, , +22

Laboratory Identification of Clinically Important Aerobic Actinomycetes

David Berd · Applied Microbiology · 1973 · 166 citations · Full text

, , +12

Rows per page

1–5 of 77